The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Odronextamab
Odronextamab · ODRONEXTAMAB 2 mg/mL · Injection, Solution · Catalent Indiana, LLC
NDC 61434-0064-00 · 884 VIAL in 1 CASE / 2 mL in 1 VIAL · EXPORT ONLY · View full market →
Medicare Part D
This product is labeled for export only and is not sold to US patients, so Medicare does not price it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Odronextamab (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Catalent Indiana, LLC | ODRONEXTAMAB 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Indiana, LLC | ODRONEXTAMAB 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Odronextamab — NDC 61434-0064-00," retrieved September 3, 2026, https://drugdashboards.com/drug/61434006400.
Free to cite with attribution — see how the data is put together.